Neil Bhowmick
Neil Bhowmick is Chief Scientific Officer at Kairos Pharma and holds the Mark Goodson Chair in Oncology Research. He is also a Professor in the Department of Medicine at Cedars-Sinai Medical Center in Los Angeles, California. His research focuses on tumour–host interactions and the mechanisms underlying cancer drug resistance. His work has been cited more than 18,000 times and has contributed to the development of several interventions currently in preclinical and clinical testing across multiple cancer types.
ArticleAnticipating adaptation: understanding and overcoming cancer drug resistance
Neil Bhowmick explores how understanding the mechanisms of cancer drug resistance has reframed our approach to treatment, revealing containment and control as realistic goals for therapeutic strategies.